Publicaciones (93) Publicaciones en las que ha participado algún/a investigador/a

2021

  1. Acute intermittent porphyria, givosiran, and homocysteine

    Journal of Inherited Metabolic Disease

  2. Additional causal SNRPE mutations in hereditary hypotrichosis simplex

    British Journal of Dermatology

  3. Author Correction: A community-based transcriptomics classification and nomenclature of neocortical cell types (Nature Neuroscience, (2020), 23, 12, (1456-1468), 10.1038/s41593-020-0685-8)

    Nature Neuroscience

  4. Author Correction: Epilepsy and neuropsychiatric comorbidities in mice carrying a recurrent Dravet syndrome SCN1A missense mutation (Scientific Reports, (2019), 9, 1, (14172), 10.1038/s41598-019-50627-w)

    Scientific Reports

  5. Author Correction: Gene regulation by long non-coding RNAs and its biological functions (Nature Reviews Molecular Cell Biology, (2021), 22, 2, (96-118), 10.1038/s41580-020-00315-9)

    Nature Reviews Molecular Cell Biology

  6. Bariatric Embolization: A Procedure Dead or Alive?

    CardioVascular and Interventional Radiology

  7. Benefits of Bariatric Surgery Prior to SARS-CoV-2 Infection in Modulating the Response to COVID-19

    Obesity

  8. COVID-19 in patients with hematological malignancies: Considering the role of tyrosine kinase inhibitors

    Cancer

  9. Cagrilintide plus semaglutide for obesity management

    The Lancet

  10. Clarification of Definitions of Hyperprogressive Disease during Immunotherapy

    JAMA Oncology

  11. Correction to: Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS (Intensive Care Medicine, (2020), 46, 12, (2200-2211), 10.1007/s00134-020-06192-2)

    Intensive Care Medicine

  12. Correction to: Dietary folate intake and metabolic syndrome in participants of PREDIMED‑Plus study: a cross‑sectional study (European Journal of Nutrition, (2021), 60, 2, (1125-1136), 10.1007/s00394-020-02364-4)

    European Journal of Nutrition

  13. Correction: Current and novel therapeutic opportunities for systemic therapy in biliary cancer (British Journal of Cancer, (2020), 123, 7, (1047-1059), 10.1038/s41416-020-0987-3)

    British Journal of Cancer

  14. Corrigendum to ‘The forefront of ovarian cancer therapy: update on PARP inhibitors': [Annals of Oncology 31 (2020) 1148–1159] (Annals of Oncology (2020) 31(9) (1148–1159), (S0923753420398914), (10.1016/j.annonc.2020.06.004))

    Annals of Oncology

  15. Corrigendum to “Corrigendum to Hydroxyethyl starch and acute kidney injury in high-risk patients undergoing cardiac surgery: A prospective multicenter study” [J Clin Anesth 2021 Oct;73:110367] (Journal of Clinical Anesthesia (2021) 73, (S0952818021002063), (10.1016/j.jclinane.2021.110367))

    Journal of Clinical Anesthesia

  16. Corrigendum to “Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules” [J Hepatol (2019) 874–884] (Journal of Hepatology (2019) 70(5) (874–884), (S0168827819300157), (10.1016/j.jhep.2019.01.005))

    Journal of Hepatology

  17. Cutaneous squamous cell carcinoma presenting with facial paralysis: good response to Cemiplimab

    JDDG - Journal of the German Society of Dermatology

  18. Double identification of sentinel lymph node with indocyanine green and 99m-technetium in vulvar cancer and V-Y flap for vulvar reconstruction

    International Journal of Gynecological Cancer

  19. Durvalumab as a successful downstaging therapy for liver transplantation in hepatocellular carcinoma: The importance of a washout period

    Transplantation

  20. ESGO/ISUOG/IOTA/ESGE Consensus Statement on preoperative diagnosis of ovarian tumors

    Ultrasound in Obstetrics and Gynecology